|
MechanismBacterial DNA gyrase inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1989 |
100 Clinical Results associated with Shandong Lukang Dongyue Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Shandong Lukang Dongyue Pharmaceutical Co. Ltd.
100 Deals associated with Shandong Lukang Dongyue Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Shandong Lukang Dongyue Pharmaceutical Co. Ltd.